Skip to product information
1 of 1

EL837 Human Lymphocyte Expansion Medium, Serum-Free

EL837 Human Lymphocyte Expansion Medium, Serum-Free

Cellarom Store

Request for Quote

EL837 Human Lymphocyte Expansion Medium, Serum-Free is a professional medium designed for human lymphocyte induction and expansion. This advanced formulation delivers superior performance and reliability for culturing NK cells, CIK cells, and T cells.

Its xeno-free and chemically-defined composition makes EL837 a safe, stable, and superior choice for research and clinical applications. Lymphocytes induced or expanded with EL837 maintain full functionality, ensuring greater efficiency in downstream applications and analysis.

Available in RUO

  • Chemically Defined Media, Xenogenic Free
  • No human Albumin, transferrin, insulin

Read the Complete Guide

Application

EL837 is a excellent and professional medium for human lymphocyte induction and expansion. Xeno-free and chemically-defined composition brings EL837 as a safe, stable and superior material for research, further in clinical application Add 5-10% auto serum or substitution (3-5% EliteGro Adv.) in cell culture. Add IL-2 into complete medium with at least 500 U/ml. Seeding lymphocyte density between 0.5-2 x10^6/ml

Cell Type

NK, CIK, T cell

Storage

  • 2-8 C protect from light for NK media

Specification

  • Suitable for MNC (mononuclear cells) from whole blood and cord blood source.
  • 70%-90% NK cells (CD3-CD56+) at Day 14.
  • 1.0- 2.0 x10^9 total cells (per L) at Day 14.
  • 80%-100% cytotoxicity at E/T ratio 5:1, better efficacy.
View full details

Request for Quote

Contact us for quote and additional information

Scale up your NK development work from discovery to clinical trials

Xeno-free and chemically-defined composition brings EL837 as a safe, stable and superior material for research, further in clinical application. Fully functional lymphocytes induced or expanded by EL837 will be more efficient in further application and analysis.

Cellarom was born from a desire to bridge the gap between research and development, pilot production and commercialization. We recognized the challenge of balancing scientifically acceptable product performance with the need to reduce manufacturing costs to produce cost-effective therapies.

At Cellarom, we are dedicated to:

  • Bridging Product Development and Commercialization in Cell Therapy
  • Cost-Effective and High-Quality Cell Therapy raw materials and solutions
  • Capability for Scaling Up Cell Therapy Production